UK regulator suspends Amgen's Tavneos for new patients after unreliable trial data. Approval may be revoked by 2027. Patients ...
Dili, an AI-powered compliance company focused on U.S. infrastructure projects, announced a $15 million Series A funding round. The raise follows a previous $6.7 million seed round, bringing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results